| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 04/23/2003 | EP0986575B1 Method for preparing salts of aspartame from n-protected aspartame |
| 04/23/2003 | EP0836615B1 New thrombin inhibitors, their preparation and use |
| 04/23/2003 | CN1413218A Aspartame derivative crystals |
| 04/23/2003 | CN1413214A Peptide beta turn mimetic compounds and process for making them |
| 04/22/2003 | US6552216 Molecular model for VLA-4 inhibitors |
| 04/22/2003 | US6552168 Inhibition of apoptosis via attenuation of caspase activity should therefore be useful in the treatment of human diseases where inappropriate apoptosis is prominent or contributes to disease pathogenesis |
| 04/22/2003 | US6552038 Anticoagulant agents |
| 04/22/2003 | US6552013 For therapy of Alzheimer's disease |
| 04/22/2003 | US6551998 Therapy and prophylaxis of bacterial infection in a mammal by administering peptide antibiotic compound |
| 04/22/2003 | US6551799 Nucleotide sequences coding polypeptide for use in diagnosis and treatment of pancreatic defects |
| 04/22/2003 | US6551574 Tuftsin receptor-specific peptides, peptidomimetics and peptide-like constructs for use in biological, pharmaceutical and radiopharmaceutical applications, in which peptide is conformationally fixed on complexation with metal ion |
| 04/22/2003 | CA2308780C Novel derivatives of 2,3-methanoamino acids, process for their preparation and pharmaceutical compositions containing them |
| 04/22/2003 | CA2101075C Peptides for the treatment of conditions caused by herpes virus infections |
| 04/17/2003 | WO2003031623A1 Cocoa flavour precursor peptides |
| 04/17/2003 | WO2003031574A2 Elastase inhibitors |
| 04/17/2003 | WO2003031467A2 Amino-substituted camptothecin polymer derivatives and use of the same for the manufacture of a medicament |
| 04/17/2003 | WO2003031410A1 Ligands of melanocortin receptors and compositions and methods related thereto |
| 04/17/2003 | WO2003030925A1 Angiogenesis drugs |
| 04/17/2003 | WO2003022872A3 Crystal form of lisinopril monohydrate |
| 04/17/2003 | WO2002094985A3 Beta-secretase substrates and uses thereof |
| 04/17/2003 | WO2002032291A9 Imaging of enzymatic activity |
| 04/17/2003 | WO1998004278A3 Tetrapeptide derivatives of dolastatin as antitumor agents |
| 04/17/2003 | US20030073852 Anticancer agents |
| 04/17/2003 | US20030073807 Bi-directional synthesis of oligoguanidine transport agents |
| 04/17/2003 | US20030073721 Central nervous system disorders; Alzheimer's disease; genetic engineering |
| 04/17/2003 | US20030073618 Compounds comprising disulfide-containing peptides and nitrogenous bases, and medical uses thereof |
| 04/16/2003 | EP1302476A1 Reduced fk228 and use thereof |
| 04/16/2003 | EP1302468A1 Processes and intermediates for manufacturing retroviral protease inhibiting compounds |
| 04/16/2003 | EP1302207A2 Method for preparing an antihypertensive agent containing a dipeptide as active ingredient |
| 04/16/2003 | EP1301604A2 Substrates and assays for beta-secretase activity |
| 04/16/2003 | EP1301540A2 Rgd (arg-gly-asp) coupled to neuropeptides |
| 04/16/2003 | EP1301498A1 Colchinol derivatives as angiogenesis inhibitors |
| 04/16/2003 | EP1301486A2 Imidazolidinones as ns3-serine protease inhibitors of hepatitis c virus |
| 04/16/2003 | EP1224211B1 Process for the preparation of a dipeptide and intermediate product in such a process |
| 04/16/2003 | EP0931038B1 Novel substance library and supramolecular complexes produced therewith |
| 04/16/2003 | EP0873404B1 Angiotensin converting enzyme inhibitors |
| 04/16/2003 | EP0824544B1 Peptidyl compounds which inhibit metalloproteinase and tnf liberation and their therapeutic use |
| 04/16/2003 | EP0804481B1 Somatostatin derivatives and their radiolabelled products |
| 04/16/2003 | EP0773955B1 New thrombin inhibitors, their preparation and use |
| 04/16/2003 | EP0769958B1 Inhibitors of leukocyte adhesion |
| 04/16/2003 | EP0750508B1 RETROPEPTIDES, ANTIBODIES THERETO, AND USES THEREOF FOR VACCINATION AND $i(IN VITRO) DIAGNOSIS |
| 04/16/2003 | EP0649414B1 Opioid diarylmethylpiperazines and piperidines |
| 04/16/2003 | CN1411509A Process for producing Kiss-1 peptide |
| 04/16/2003 | CN1410447A Sequence number3 bioactive peptide |
| 04/16/2003 | CN1410446A Sequence number4 bioactive peptide |
| 04/16/2003 | CN1410445A Sequence number5 bioactive peptide |
| 04/16/2003 | CN1410444A Sequence number9 bioactive peptide |
| 04/16/2003 | CN1410443A Sequence number8 bioactive peptide |
| 04/16/2003 | CN1410442A Sequence number1 bioactive peptide |
| 04/16/2003 | CN1410441A Sequence number2 bioactive peptide |
| 04/16/2003 | CN1410440A Sequence number6 bioactive peptide |
| 04/16/2003 | CN1410439A Sequence number10 bioactive peptide |
| 04/16/2003 | CN1410438A Sequence no.25 bioactive peptide |
| 04/16/2003 | CN1105715C New pyridonecarboxylic acid derivatives or their salts and antibacterial agent comprising same as active ingredient |
| 04/15/2003 | US6548679 Antitumor agents |
| 04/15/2003 | US6548668 Stabilizer for proteins |
| 04/15/2003 | US6548664 Alkylation, hydrogenation, cyclization, condensation, deracemization |
| 04/15/2003 | US6548663 Benzodiazepine vitronectin receptor antagonist pharmaceuticals |
| 04/15/2003 | US6548638 Peptoid and nonpeptoid containing α-keto oxadiazoles as serine protease inhibitors |
| 04/15/2003 | US6548637 Endomorphine analog analgesics |
| 04/15/2003 | US6548500 Treating a cell adhesion-mediated diseases such as multiple sclerosis, asthma, atherosclerosis, rheumatoid arthritis, meningitis, comprising administering to a warm blooded animal a nitrogen atoms containing bicyclic compound |
| 04/15/2003 | US6548481 A salt form of a dipeptide compound formed from an amino acid and a thiazolidine or pyrrolidine group, and the salts are selected from acetates, tartrates, fumarates, succinates, phosphates and sulfates |
| 04/15/2003 | US6548480 Reacting a phosphorylated derivatives with a dipeptide to displace halogen atom of phosphorylated derivative, deprotecting to form a phosphonic acid derivative; neutral endopeptidase and angiotensin converting enzyme inhibitor |
| 04/15/2003 | US6548479 Fused bicyclic peptides are administered to an animal to inhibit the proliferation of CD4 T-cells |
| 04/15/2003 | US6548477 Therapeutic agents and methods of use thereof for the modulation of angiogenesis |
| 04/15/2003 | US6548476 Dimeric inhibitors of influenza neuraminidase |
| 04/15/2003 | US6548096 Aspartyl dipeptide ester derivatives and sweeteners |
| 04/15/2003 | CA2296466C Alatrofloxacin parenteral compositions |
| 04/10/2003 | WO2003029495A2 Coniosulphides and their derivatives, method for their production and use as medicaments |
| 04/10/2003 | WO2003029292A2 Gene regulatory peptides |
| 04/10/2003 | WO2002092622A3 Dipeptide derivatives having a n-terminal 2-thioacyl group as vasopeptidase inhibitors |
| 04/10/2003 | WO2002042414A3 Amino acid conjugates providing for sustained systemic concentrations of gaba analogues |
| 04/10/2003 | US20030069445 Biological reagents and methods for determining the mechanism in the generation of beta-amyloid peptide |
| 04/10/2003 | US20030069431 Method for synthesis of perindopril and its pharmaceutically acceptable salts |
| 04/10/2003 | US20030069392 Cationic lipids |
| 04/10/2003 | US20030069228 Capase inhibitors; antiinflammatory agents |
| 04/10/2003 | US20030069222 Used as anti-viral agents against the HIV-1 and HIV-2 viruses. |
| 04/10/2003 | US20030069187 Naturally occurring novel elastin derived oligopeptides, having the formula AFP, VPG and AGIP; determining the severity of a disease characterized by elevated activity of an elastolytic serine protease |
| 04/10/2003 | US20030069181 Alternative splice forms of proteins as basis for multiple therapeutic modalities |
| 04/10/2003 | US20030069175 A cyclic peptide, e.g., cyclic (Tyr-Gly-Phe-Gly-Gly) useful for stimulating the formation of osteoblastic or fibroblastic cells, enhancing bone formation, repairing fractures, healing wounds, grafting intraosseous implants, etc. |
| 04/10/2003 | US20030069169 Co-administration of melanocortin receptor agonist and phosphodiesterase inhibitor for treatment of cyclic-AMP associated disorders |
| 04/10/2003 | US20030068674 Method of producing a biosensor protein capable of regulating a fluorescence property of green fluorescent protein, and the biosensor protein produced by the method |
| 04/10/2003 | US20030068321 Methods of effecting neuronal activity |
| 04/10/2003 | CA2768340A1 Copolymers for suppression of autoimmune diseases, and methods of use |
| 04/10/2003 | CA2462796A1 Gene regulatory peptides |
| 04/09/2003 | EP1300418A1 Gene regulation by oligopeptides |
| 04/09/2003 | EP1300416A1 Memory-enhancing peptides and the use thereof |
| 04/09/2003 | EP1300397A1 Compound for protective and anchor groups and its use |
| 04/09/2003 | EP1106624B1 5-membered ring compounds |
| 04/09/2003 | EP0768898B1 Cascade-polymer complexes and methods of producing the same |
| 04/09/2003 | CN1104851C Granular sweetener |
| 04/08/2003 | US6545162 Solid phase biosynthesis of viricide antibiotic |
| 04/08/2003 | US6545127 Catalytically active recombinant memapsin and methods of use thereof |
| 04/08/2003 | US6545123 Synthesis without the use of the cells and their use in vivo as powerful anti-inflammatory, antithrombotic or anti-metastatic compounds |
| 04/08/2003 | US6544977 Crystalline forms of 1s-[1-alpha(2s*,3r*), 9alpha]6, 10-dioxo-n-(2-ethoxy-5-oxo-tetrahydro-3-furanyl)-9[[(1-isoquinolyl)carbonyl]amino]octahydro-6h-pyridazino [1,2-a] [1,2] diazepin-1-carboxamide |
| 04/08/2003 | US6544951 Antiinflammatory agents; autoimmune diseases, nervous system degradation |
| 04/08/2003 | CA2098098C Tetrapeptides deriving from dalbaheptide antibiotics |
| 04/03/2003 | WO2003027091A1 Pyrane derivatives as both ace- and nep- inhibitors |
| 04/03/2003 | WO2003027081A2 NOVEL LIGANDS FOR THE HisB10 Zn2+ SITES OF THE R-STATE INSULIN HEXAMER |
| 04/03/2003 | WO2003026645A1 Tetrapeptide derivative crystals |